These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4985581)

  • 1. Isoniazid-resistant tuberculous superinfection.
    Greenberg HB
    J Am Geriatr Soc; 1970 May; 18(5):370-7. PubMed ID: 4985581
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
    Verbist L; Mbete S; Van Landuyt H; Darras T; Gyselen A
    Chest; 1972 Jun; 61(6):555-63. PubMed ID: 4624278
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to treatment with isoniazid plus PAS of tuberculous patients with primary isoniazid resistance.
    Tripathy SP; Menon NK; Mitchison DA; Narayana AS; Somasundaram PA; Stott H; Velu S
    Tubercle; 1969 Sep; 50(3):257-68. PubMed ID: 4981496
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary isoniazid-resistant tuberculosis in children. Clinical features, strain resistance, treatment, and outcome in 26 children treated at Kings County Medical Center of Brooklyn between the years 1961 and 1972.
    Steiner P; Rao M; Victoria M; Steiner M
    Am Rev Respir Dis; 1974 Sep; 110(3):306-11. PubMed ID: 4213311
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Relationship between the incidence of drug resistance and the course of original treatment].
    Yamamoto M; Nakamura H
    Kekkaku; 1971 Jun; 46(6):191-5. PubMed ID: 4997826
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.
    Vall-Spinosa A; Lester W; Moulding T; Davidson PT; McClatchy JK
    N Engl J Med; 1970 Sep; 283(12):616-21. PubMed ID: 4988918
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid-resistant cavitary tuberculosis in a physician following isoniazid prophylaxis.
    Karchmer TB; Phipps JD; Giannetta ET; Farr BM
    Infect Control Hosp Epidemiol; 2002 Oct; 23(10):622-5. PubMed ID: 12400895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study.
    Favez G; Chioléro R; Willa C
    Chest; 1972 Jun; 61(6):583-6. PubMed ID: 4624280
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
    Tubercle; 1973 Mar; 54(1):23-45. PubMed ID: 4204397
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endocavernous treatment of caverns with atypical Mycobacteria].
    Neef W
    Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):385-9. PubMed ID: 5210837
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of 200 cases of active, recent pulmonary tuberculosis treated with rifampin-isoniazid. A follow-up history of one and one-half to three years.
    Constans P; Baron A; Parrot R; Coury C
    Chest; 1972 Jun; 61(6):539-49. PubMed ID: 4624276
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of patients with caseous tuberculosis of the lungs with individual maximally tolerated doses of Tubazid].
    Bondarev IM; Tarasova EF; Noskova GP; Oblogina VV; Kanevskaia SS
    Probl Tuberk; 1972; 50(8):8-12. PubMed ID: 4626693
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antituberculosis efficacy of rifampin in 136 patients.
    Davidson PT; Goble M; Lester W
    Chest; 1972 Jun; 61(6):574-8. PubMed ID: 4624279
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of single and divided daily dosages of isoniazid and PAS in the treatment of pulmonary tuberculosis. XV. A report of the Veterans Administration-Armed Forces Cooperative. Study on the chemotherapy of tuberculosis.
    Reisner D
    Am Rev Respir Dis; 1966 Dec; 94(6):849-57. PubMed ID: 4958797
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary drug-resistant tuberculosis in active-duty military personnel: 1959-1968.
    Briney RR; Cowley RG
    Am Rev Respir Dis; 1970 May; 101(5):700-2. PubMed ID: 4986424
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis.
    Fairshter RD; Randazzo GP; Garlin J; Wilson AF
    Am Rev Respir Dis; 1975 Jul; 112(1):37-42. PubMed ID: 807140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous reinfection with Mycobacterium tuberculosis confirmed by phage typing.
    Raleigh JW; Wichelhausen R
    Am Rev Respir Dis; 1973 Sep; 108(3):639-42. PubMed ID: 4200815
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary drug resistance of Mycobacterium tuberculosis in Kazakhstan].
    Krivtsova AE; Blagodarnyĭ IaA
    Probl Tuberk; 1974; (8):70-3. PubMed ID: 4277905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.